Skip to content

Insider · CIK 0001974888

Venkatesh Srinivasan

officer

Files at STRO (SUTRO BIOPHARMA, INC.). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 1, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+2,500$0.00$054,580May 5, 2025
May 1, 2025STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock
-894$1.07$95753,686May 5, 2025
May 1, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-2,500$0.00$05,000May 5, 2025
Apr 11, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock
+21,250$0.00$059,683Apr 15, 2025
Apr 11, 2025STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock
-7,603$0.60$4,56252,080Apr 15, 2025
Apr 11, 2025STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative
-21,250$0.00$021,250Apr 15, 2025
Apr 4, 2025STRO
SUTRO BIOPHARMA, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+101,500$0.00$0101,500Apr 8, 2025
Apr 4, 2025STRO
SUTRO BIOPHARMA, INC.
AGrant or award
Restricted Stock Units (RSUs)derivative
+94,250$0.00$094,250Apr 8, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Venkatesh Srinivasan: insider trades and track record | InsiderTell